Sami vs Pfizer
Side-by-side comparison of AI visibility scores, market position, and capabilities
Sami is a Brazilian digital health plan and primary care company offering app-based unlimited consultations, dedicated health teams, and hospital network access; raised $23M+ in funding;
About
Sami is a Brazilian health technology and health plan company founded in 2018 by Vitor Asseituno and Guilherme Berardo and headquartered in São Paulo, Brazil. The company provides a modern health plan alternative to Brazil's fragmented and costly private health insurance market — offering individuals and small businesses a comprehensive health membership that includes unlimited primary care consultations (via app or in person), access to a dedicated health team, preventive care coordination, and a curated network of hospitals, specialists, and wellness services.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
About
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.